CLDN18.2 in colorectal mucinous adenocarcinoma: a lineage-associated biomarker and emerging translational target.
- DOI
- 10.3389/fphar.2026.2001935
- Published
- 2026
- Container
- Frontiers in pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2026.2001935,
title = {CLDN18.2 in colorectal mucinous adenocarcinoma: a lineage-associated biomarker and emerging translational target.},
author = {Yu W and Wei S and Wan S and Chen Y and Huang Q},
year = {2026},
journal = {Frontiers in pharmacology},
doi = {10.3389/fphar.2026.2001935},
url = {https://doi.org/10.3389/fphar.2026.2001935}
}RIS
TY - JOUR TI - CLDN18.2 in colorectal mucinous adenocarcinoma: a lineage-associated biomarker and emerging translational target. AU - Yu W AU - Wei S AU - Wan S AU - Chen Y AU - Huang Q PY - 2026 JO - Frontiers in pharmacology DO - 10.3389/fphar.2026.2001935 UR - https://doi.org/10.3389/fphar.2026.2001935 ER -
APA
W, Y., S, W., S, W., Y, C., & Q, H. (2026). CLDN18.2 in colorectal mucinous adenocarcinoma: a lineage-associated biomarker and emerging translational target.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.2001935
Source records
- pubmed · retrieved 2026-11-10T09:27:22.789Z